Page last updated: 2024-11-12

rocagloic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rocagloic acid: from leaves of Aglaia elliptifolia: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AglaiagenusA plant genus of the family MELIACEAE. Members contain lariciresinol, pregnanes, insecticidal rocaglamide derivatives and other compounds.[MeSH]MeliaceaeThe mahogany plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID10322821
CHEMBL ID518601
SCHEMBL ID750035
MeSH IDM0390257

Synonyms (9)

Synonym
rocagloic acid
CHEMBL518601
SCHEMBL750035
190385-15-0
(1r,2r,3s,3ar,8bs)-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-3-phenyl-2,3-dihydro-1h-cyclopenta[b][1]benzofuran-2-carboxylic acid
CS-0015423
F82075
MS-28886
HY-19355
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1272156Inhibition of e1F4A1 (unknown origin) in rabbit reticulocyte assessed as capped-dependent translation incubated for 1 hr by dual glo luciferase assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Total synthesis of a biotinylated rocaglate: Selective targeting of the translation factors eIF4AI/II.
AID358825Cytotoxicity against human A549 cells2001Journal of natural products, Jan, Volume: 64, Issue:1
Cytotoxic constituents from leaves of Aglaia elliptifolia.
AID358828Cytotoxicity against human KB cells2001Journal of natural products, Jan, Volume: 64, Issue:1
Cytotoxic constituents from leaves of Aglaia elliptifolia.
AID358827Cytotoxicity against human HT-29 cells2001Journal of natural products, Jan, Volume: 64, Issue:1
Cytotoxic constituents from leaves of Aglaia elliptifolia.
AID399945Cytotoxicity against human telomerase reverse transcriptase expressing human RPE1 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.
AID399944Cytotoxicity against human Lu1 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.
AID358829Cytotoxicity against mouse P388 cells2001Journal of natural products, Jan, Volume: 64, Issue:1
Cytotoxic constituents from leaves of Aglaia elliptifolia.
AID399941Cytotoxicity against HUVEC2004Journal of natural products, Mar, Volume: 67, Issue:3
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.
AID358826Cytotoxicity against human HL60 cells2001Journal of natural products, Jan, Volume: 64, Issue:1
Cytotoxic constituents from leaves of Aglaia elliptifolia.
AID399942Cytotoxicity against human KB cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.
AID399943Cytotoxicity against human LNCAP cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.
AID399940Cytotoxicity against human Col2 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's4 (30.77)24.3611
2020's4 (30.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.96 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]